| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Monika Bradl, Yoko Kanamori, Ichiro Nakashima, Tatsuro Misu, Kazuo Fujihara, Hans Lassmann, Jürgen Sandkühle. Pain in neuromyelitis optica--prevalence, pathogenesis and therapy. Nature reviews. Neurology. vol 10. issue 9. 2014-10-27. PMID:25072195. |
terrible, agonizing, wretched, sickening and unbearable--these are words frequently used by patients with neuromyelitis optica (nmo) to describe a very common symptom of their disease: pain. |
2014-10-27 |
2023-08-13 |
Not clear |
| Marios C Papadopoulos, Jeffrey L Bennett, Alan S Verkma. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nature reviews. Neurology. vol 10. issue 9. 2014-10-27. PMID:25112508. |
neuromyelitis optica (nmo) is an autoimmune disease of the cns that is characterized by inflammatory demyelinating lesions in the spinal cord and optic nerve, potentially leading to paralysis and blindness. |
2014-10-27 |
2023-08-13 |
Not clear |
| Peter Yat-Ming Woo, Jennifer Hiu-Fung Chiu, Kar-Ming Leung, Kwong-Yau Cha. Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature. Asian spine journal. vol 8. issue 5. 2014-10-27. PMID:25346824. |
she was subsequently diagnosed to have neuromyelitis optica (nmo), a rare idiopathic inflammatory demyelinating disorder, when the clinical examination revealed left optic atrophy. |
2014-10-27 |
2023-08-13 |
Not clear |
| Aiyu Lin, Jiting Zhu, Xiaoping Yao, Shifang Lin, Shenxing Murong, Zhiwen L. Clinical manifestations and spinal cord magnetic resonance imaging findings in Chinese neuromyelitis optica patients. European neurology. vol 71. issue 1-2. 2014-10-23. PMID:24281652. |
neuromyelitis optica (nmo) is a disease distinct from multiple sclerosis in terms of clinical and magnetic resonance imaging (mri) manifestations. |
2014-10-23 |
2023-08-12 |
Not clear |
| Michael Levy, Maureen A Meal. Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica. Neurology(R) neuroimmunology & neuroinflammation. vol 1. issue 1. 2014-10-23. PMID:25340061. |
to minimize complement-mediated damage in acute relapses of neuromyelitis optica (nmo) by adding treatment with a complement inhibitor, purified c1-esterase inhibitor, to the current standard of care (high-dose glucocorticoids). |
2014-10-23 |
2023-08-13 |
human |
| Jeffrey M Gelfand, Jennifer Cotter, Jeffrey Klingman, Eric J Huang, Bruce A C Cre. Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO. Neurology(R) neuroimmunology & neuroinflammation. vol 1. issue 3. 2014-10-23. PMID:25340086. |
to describe the clinical course and neuropathology at autopsy of a patient with neuromyelitis optica (nmo) treated with alemtuzumab. |
2014-10-23 |
2023-08-13 |
Not clear |
| Ying Chen, Rui Li, Ai Ming Wu, Ya Qing Shu, Zheng Qi Lu, Xue Qiang H. The complement and immunoglobulin levels in NMO patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 35. issue 2. 2014-10-21. PMID:23881468. |
since the discovery of aquaporin-4 (aqp4) antibody a decade ago, neuromyelitis optica (nmo) has been distinguished from multiple sclerosis (ms). |
2014-10-21 |
2023-08-12 |
Not clear |
| Sherri Sandy, Sean J Pittock, Terence A R Seemungal, Amza Al. Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease. Neurology international. vol 6. issue 3. 2014-10-13. PMID:25309712. |
epidemiological studies of neuromyelitis optica (nmo) in jamaica are lacking. |
2014-10-13 |
2023-08-13 |
Not clear |
| Silvia N Tenembau. Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents. Clinical neurology and neurosurgery. vol 115 Suppl 1. 2014-10-02. PMID:24321150. |
however, there is published experience on the use of disease modifying therapies in children and adolescents with ms. neuromyelitis optica (nmo) is an autoimmune inflammatory disease preferentially targeting the optic nerves and spinal cord. |
2014-10-02 |
2023-08-12 |
Not clear |
| Christiane Wegne. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica. Clinical neurology and neurosurgery. vol 115 Suppl 1. 2014-10-02. PMID:24321153. |
in addition to focal lesions, diffuse wide-spread changes including neuroaxonal degeneration and compartmentalized inflammation are likely to contribute to increasing disability in progressive ms. neuromyelitis optica (nmo) is classically characterized by severe transverse myelitis and optic neuritis, but brain lesions are also present in the majority of nmo patients. |
2014-10-02 |
2023-08-12 |
Not clear |
| Dimitrios Karussi. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. Journal of autoimmunity. vol 48-49. 2014-10-02. PMID:24524923. |
these include the initial events of demyelination defined as clinically or radiologically isolated syndromes (cis and ris respectively), acute disseminated encephalomyelitis (adem) and its variants (acute hemorrhagic leukoencephalitis-ahl, marburg variant, and balo's concentric sclerosis), schilder's sclerosis, transverse myelitis, neuromyelitis optica (nmo and nmo spectrum of diseases), recurrent isolated optic neuritis and tumefactive demyelination. |
2014-10-02 |
2023-08-12 |
Not clear |
| N Collongues, C Papeix, H Zéphir, B Audoin, F Cotton, F Durand-Dubief, S Vukusic, D Brassat, D Laplaud, R Marignie. [Nosology and etiologies of acute longitudinally extensive transverse myelitis]. Revue neurologique. vol 170. issue 1. 2014-10-01. PMID:24269116. |
the role of mri in the exploration of myelitis has increased recently after the individualization of neuromyelitis optica (nmo) in 2004. |
2014-10-01 |
2023-08-12 |
human |
| Norio Chihara, Toshimasa Aranami, Shinji Oki, Takako Matsuoka, Masakazu Nakamura, Hitaru Kishida, Kazumasa Yokoyama, Yoshiyuki Kuroiwa, Nobutaka Hattori, Tomoko Okamoto, Miho Murata, Tatsushi Toda, Sachiko Miyake, Takashi Yamamur. Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. PloS one. vol 8. issue 12. 2014-09-30. PMID:24340077. |
neuromyelitis optica (nmo) is an inflammatory disease characterized by recurrent attacks of optic neuritis and myelitis. |
2014-09-30 |
2023-08-12 |
Not clear |
| Sung-Min Kim, Junwoo Park, Sun Hee Kim, Su-Yeon Park, Jee Young Kim, Jung-Joon Sung, Kyung Seok Park, Kwang-Woo Le. Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects. PloS one. vol 8. issue 12. 2014-09-30. PMID:24358171. |
neuromyelitis optica (nmo) is an inflammatory demyelinating disorder of the central nervous system with a relapsing and remitting course. |
2014-09-30 |
2023-08-12 |
Not clear |
| Markus C Kowarik, John Soltys, Jeffrey L Bennet. The treatment of neuromyelitis optica. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 34. issue 1. 2014-09-30. PMID:24531318. |
neuromyelitis optica (nmo) is an autoimmune disorder of the central nervous system directed against astrocytes. |
2014-09-30 |
2023-08-12 |
human |
| Wataru Shiraishi, Shintaro Hayashi, Takashi Kamada, Noriko Isobe, Ryo Yamasaki, Hiroyuki Murai, Yasumasa Ohyagi, Jun-ichi Kir. A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy. Multiple sclerosis (Houndmills, Basingstoke, England). vol 20. issue 2. 2014-09-24. PMID:24263387. |
we report the first case of definite neuromyelitis optica (nmo) with a pathogenic mitochondrial dna (mtdna) mutation for leber's hereditary optic neuropathy (lhon) (g11778a point mutation). |
2014-09-24 |
2023-08-12 |
Not clear |
| Rui Li, Xiaonan Zhong, Wei Qiu, Aimin Wu, Yongqiang Dai, Zhengqi Lu, Xueqiang H. Association between neuromyelitis optica and tuberculosis in a Chinese population. BMC neurology. vol 14. 2014-09-23. PMID:24555792. |
a number of reports have described the presence of tuberculosis (tb) in neuromyelitis optica (nmo) patients. |
2014-09-23 |
2023-08-12 |
Not clear |
| Jason Yongha Kim, Joon Seol Bae, Ho Jin Kim, Hyoung Doo Shi. CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population. BMC neurology. vol 14. 2014-09-23. PMID:24655566. |
neuromyelitis optica (nmo) is a serious inflammatory demyelinating disease (idd), characterized by the inflammation and demyelination of optic nerves and spinal cords, which subsequently leads to the loss of function. |
2014-09-23 |
2023-08-12 |
Not clear |
| Corinna Trebst, Sven Jarius, Achim Berthele, Friedemann Paul, Sven Schippling, Brigitte Wildemann, Nadja Borisow, Ingo Kleiter, Orhan Aktas, Tania Kümpfe. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). Journal of neurology. vol 261. issue 1. 2014-09-19. PMID:24272588. |
neuromyelitis optica (nmo, devic's syndrome), long considered a clinical variant of multiple sclerosis, is now regarded as a distinct disease entity. |
2014-09-19 |
2023-08-12 |
Not clear |
| Corinna Trebst, Sven Jarius, Achim Berthele, Friedemann Paul, Sven Schippling, Brigitte Wildemann, Nadja Borisow, Ingo Kleiter, Orhan Aktas, Tania Kümpfe. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). Journal of neurology. vol 261. issue 1. 2014-09-19. PMID:24272588. |
in this review, the neuromyelitis optica study group (nemos) summarizes recently obtained knowledge on nmo and highlights new developments in its diagnosis and treatment, based on current guidelines, the published literature and expert discussion at regular nemos meetings. |
2014-09-19 |
2023-08-12 |
Not clear |